跳至主要内容
临床试验/NL-OMON55122
NL-OMON55122已完成2 期

MR-guided LITT therapy in patients with primary irresectable glioblastoma: a randomized pilot study - EMITT-pilot study

Radboud Universitair Medisch Centrum0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • •- Informed consent, age >18-year-old
  • •- Supratentorial localization
  • •- Maximal volume <=70cc on post-contrast T1 MRI
  • •- Safe trajectory/trajectories possible for ablation of at least 70% of the
  • •tumour, avoiding eloquent structures or transgression of a ventricle or vessel.
  • •- Karnofsky Performance Status (KPS) >= 70

排除标准

  • •- Contra-indication for general anaesthesia or MRI
  • •- Lesion >70cc on post-contrast MRI on the day before intervention.
  • •- Non-glioblastoma diagnosis as per frozen section analysis
  • •- Pregnancy

研究者

相似试验